Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
about
Overview of the biology of type I interferonsEssential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunityInterferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cellsTRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunityTranscription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell developmentClinical and molecular phenotype of Aicardi-Goutieres syndromeTargeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayThe macrophages in rheumatic diseasesClearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLEMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsType I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesPredominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic AutoimmunityCpG Oligonucleotides as Cancer Vaccine AdjuvantsLinking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosusAdvances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature ReviewThe regulation of inflammation by interferons and their STATsInterleukin-27: balancing protective and pathological immunityRole of KSRP in control of type I interferon and cytokine expressionIntracellular nucleic acid sensors and autoimmunityNeutrophils in the pathogenesis and manifestations of SLEInfection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation.Structural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosusMultiple Roles for B-Lymphocytes in Sjogren's SyndromeHematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic AnemiaSexual dimorphism in autoimmunitymiRNAs in the Pathogenesis of Systemic Lupus ErythematosusTLR8 deficiency leads to autoimmunity in miceNegative regulation of interferon-β gene expression during acute and persistent virus infectionsTRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAsMouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunitySpherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cellsExcessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosisAutoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functionsTyrosine Kinase SYK Licenses MyD88 Adaptor Protein to Instigate IL-1α-Mediated Inflammatory Disease.Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axisAnalysis of the transcriptional networks underpinning the activation of murine macrophages by inflammatory mediatorsGenomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha.
P2860
Q21195364-7C01413B-FAC4-431A-B59C-5E3BB828A74AQ24312889-E401CDD8-BF80-40FC-91E8-12FA3BB54208Q24323367-106C8BEA-7582-4D9D-A7B0-F02613355EA5Q24338801-D3DEFDC8-220F-4E7C-A093-7FE3CCFEEB0DQ24645273-13B834C3-2232-481F-A062-4BE453647280Q24655458-DD761E8D-99A5-4E5A-9596-37FCF2E28782Q26746697-A8FB1AD0-6563-4E89-B1CD-60E37BB44A5FQ26765275-56D8620B-8631-4EC2-8461-B4148E4C6F21Q26767511-8D936FD6-9E11-4F03-B1BE-0519FAEEDA66Q26773183-ACA784D1-3D41-4AB6-95E1-A63FA2C97846Q26775111-09997C29-D352-4F01-98CB-D81510DEDC47Q26777199-0E8640A9-6309-42CF-BC51-4F30D944A5E8Q26783826-9CD36FAA-004F-4744-B2C0-643B06934CFDQ26822662-4A5227FA-FDB7-4555-8276-1D38C285DCBAQ26824039-D2F11DC7-0DED-4107-BB0D-326FB47582C7Q26829387-C53B0779-1294-466C-A489-27C0863FF88FQ26830400-801BBD99-DB44-42CF-A1C2-D80B208A02D4Q26860434-339A7E42-B216-4DB7-BB9B-F8377C34D4CAQ26997316-12402305-7EC2-42C5-9D8F-0D6F43378964Q27000384-80DEF641-AEE0-4462-8C8F-7EE453587E14Q27316718-11519975-828E-4DCD-9F28-698951601220Q27677078-23F814A8-D045-470D-B4A1-B72356904578Q28068695-73CDCB18-414B-4173-8890-DF1FC0502207Q28071495-51A6EE50-688E-48F9-9A5A-5E314B3E116FQ28080459-1CE4857B-4930-43BC-BFD9-3249F5A89CDFQ28083028-0A080D91-EAF4-49E0-BD91-48AC3F64FB86Q28292240-C4DCEF81-EFA4-4DBA-A690-7A820FAC5CFFQ28478468-492E8E0E-7D70-4E15-83AC-DE6EFA9BA6DBQ28513125-FD31387A-F26B-4E8B-914C-C5143D59F22DQ28538471-30DD5AB2-17B2-4357-95FC-E7148C7F275EQ28660378-48416554-D0B2-4503-8F0D-C56F9E13E397Q28730670-1E64CD6D-00CC-45DF-92CD-D893F5F8A55AQ28744592-428060EE-52D7-4DEE-809C-2B4AEAE8FA1FQ30245322-EED9DBFC-799B-45ED-BC27-3E3A37D67C0BQ30252210-C9165225-20E1-4E4F-85EF-7B176F923908Q30252629-CF60C3EB-E32E-4E56-BCCD-C6299CB6C1D0Q30422031-994F888D-7CDA-4DD5-AC5E-D4F09A0D43FEQ30423162-1950B76D-9808-4940-96F9-15A796962C58Q30633154-3972403D-8842-45D7-8097-7D77FC4C65CAQ33334070-10554D97-4FB7-4393-AEC8-A88125A58ACA
P2860
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
@ast
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
@en
type
label
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
@ast
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
@en
prefLabel
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
@ast
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
@en
P1433
P1476
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
@en
P2093
Virginia Pascual
P304
P356
10.1016/J.IMMUNI.2006.08.010
P407
P577
2006-09-01T00:00:00Z